Anthem Blue Cross

Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) fell about 5 percent Friday after Anthem Blue Cross said the clinical benefit of treatment for DMD (Duchenne Muscular Dystrophy) with the company's eteplirsen (Exondys 51), including improved motor function, has "not been demonstrated....

Shares of Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides patient management information, surged higher by more than 20 percent during Tuesday's after-hours trading session. Sequenom announced after Tuesday's market close that it has entered into a new agreement with Anthem...